MLchartDataset catalogue

Kinase inhibitor TQB3912

Term · Oncology and biomedicine · MLC-T-ONC-014644

An orally bioavailable small molecule protein kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor TQB3912 may target, bind to and inhibit the activity of a protein kinase that plays an important role in tumor cell survival, proliferation, migration, and differentiation.

Table 1. Record
IdentifierMLC-T-ONC-014644
FieldOncology and biomedicine
Synonymsprotein kinase inhibitor TQB3912
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014644",
  "term": "Kinase inhibitor TQB3912",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable small molecule protein kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor TQB3912 may target, bind to and inhibit the activity of a protein kinase that plays an important role in tumor cell survival, proliferation, migration, and differentiation.",
  "synonyms": [
    "protein kinase inhibitor TQB3912"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/kinase-inhibitor-tqb3912/"
}

Record 9,781 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.